INTERNATIONAL PATENT: KYON BIOTECH AG FILES APPLICATION FOR "HYPOTONIC FLUID FOR ENDOGENOUS RELEASE OF LIVER ARGINASE FOR CANCER TREATMENT"

GENEVA, Dec. 29 -- KYON BIOTECH AG (Hardturmstr. 1038005 Zurich) filed a patent application (PCT/EP2025/066623) for "HYPOTONIC FLUID FOR ENDOGENOUS RELEASE OF LIVER ARGINASE FOR CANCER TREATMENT" on Jun 13, 2025. With publication no. WO/2025/261935, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): TEPIC, Slobodan (c/o Kyon Biotech AGHardturmstr. 1038005 Zurich)

Abstract: The present invention relates to a hypotonic fluid, e.g., water for injection, useful for the treatment of cancer via the endogenous release of liver enz...